Raúl Peralta

Raúl Peralta

Auto-generated profile, based on publicly available information

Raúl Peralta

Centro de Investigacion en Dinamica Celular, Universidad Autonoma del Estado de Morelos

Research Focus & Metrics

Academic Career Length

22Years (2005-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
3 December 2012 in Infectious Agents and Cancer
Verified
Journal Article
Open access
PDF file
RPRaúl Peralta-Rodríguez
Raúl Peralta-Rodríguez
Pablo Romero-MorelosPablo Romero-Morelos
Pablo Romero-Morelos
VVVanessa Villegas-Ruíz
Vanessa Villegas-Ruíz
MMMónica Mendoza-Rodríguez
Mónica Mendoza-Rodríguez
KTKeiko Taniguchi-Ponciano
Keiko Taniguchi-Ponciano
MSMauricio Salcedo
Mauricio Salcedo
Background: Human Papillomavirus (HPV) in cervical epithelium has been identified as the main etiological factor in the developing of Cervical Cancer (CC), which has recently become a public health problem in Mexico. This finding has allowed for the development of vaccines that help prevent this infection. In the present study, we aimed to determine the prevalence and HPV type-distribution in Mexican women with CC, high-grade squamous intraepithelial lesion (HSIL), low-grade squamous intraepithelial lesion (LSIL), and Normal cytology (N) to estimate the impact of the HPV vaccines. Methods: The PubMed database was used to identify and review all articles that reported data on HPV prevalence in CC, precursor lesions, and normal cytology of Mexican women. Results: A total of 8,706 samples of the tissues of Mexican women were stratified according to diagnosis as follows: 499 for CC; 364 for HSIL; 1,425 for LSIL, and 6,418 for N. According to the results, the most prevalent genotypes are the following: HPV16 (63.1%), -18 (8.6%), -58, and −31 (5%) for CC; HPV-16 (28.3%), 58 (12.6%), 18 (7.4%), and 33 (6.5%) for HSIL; HPV-16 (13.1%), 33 (7.4%), 18 (4.2%), and 58 (2.6%) for LSIL, and HPV-16 (3.4%), 33 (2.1%), 18, and 58 (1.2%) for N. Conclusions: Taken together, genotypes 58 and 31 (10%) are more common than type 18 (8.6%) in CC. Therefore, the inclusion of these two genotypes in a second-generation vaccine would provide optimal prevention of CC in Mexico.

1 September 2005 in Archives of Medical Research
Verified
Journal Article
Closed access
GVGuelaguetza Vázquez-Ortíz
Guelaguetza Vázquez-Ortíz
Carlos CiudadCarlos Ciudad
Carlos Ciudad
PPPatricia Piña
Patricia Piña
KVKARLA VAZQUEZ-SANTILLAN
KARLA VAZQUEZ-SANTILLAN
AHAlfredo Hidalgo-Miranda
Alfredo Hidalgo-Miranda
MSMauricio Salcedo
Mauricio Salcedo

7 January 2010 in Journal of Cancer Research and Clinical Oncology
Verified
Journal Article
Closed access
PDF file
RPRaúl Peralta
Raúl Peralta
MBMichael Baudis
Michael Baudis
GVGuelaguetza Vazquez
Guelaguetza Vazquez
SJSergio Juárez-Méndez
Sergio Juárez-Méndez
RORocio Ortiz-Lopez
Rocio Ortiz-Lopez
MSMauricio Salcedo
Mauricio Salcedo

2 November 2011 in Journal of Clinical Pathology
Verified
Journal Article
Closed access
PDF file
RPRaúl Peralta
Raúl Peralta
AVAlejandra Valdivia
Alejandra Valdivia
IAIsabel Alvarado-Cabrero
Isabel Alvarado-Cabrero
FGFrancisco Gallegos
Francisco Gallegos
TATeresa Apresa
Teresa Apresa
MSMauricio Salcedo
Mauricio Salcedo
Aims: The authors have previously reported that cellular retinol-binding protein 1 ( CRBP1 ) gene gain and its expression correlated significantly with survival in laryngeal carcinoma patients. The authors hypothesised that inactivation of the CRBP1 gene through CpG methylation is associated with patient status and gene expression. In this work, the authors determine the expression and methylation status of the CRBP1 gene and its correlation with clinical variables of laryngeal carcinoma patients. Methods: The CRBP1 gene methylation promoter was assessed by methylation specific PCR analysis in tissue samples from larynx cancer specimens and its expression was assessed by immunohistochemistry on paraffin embedded tissue using tissue microarray. The results were then compared with the clinical pathological variables and outcome measures. The study included 46 samples from patients with non-metastatic squamous cell carcinoma of the larynx without any previous oncological treatments. Results: Lack of CRBP1 expression was seen in 17 of the 46 laryngeal carcinoma samples, while the remaining 29 samples showed increased expression. Significant associations were found between CRBP1 expression and methylation and patient status. There was a tendency for association in all clinical stages of the disease. CRBP1 gene expression and its unmethylated promoter correlated significantly with survival (p<0.05). Conclusions: An early event of larynx cancer could be CRBP1 expression related to unmethylation of the promoter region. These features could also be associated with good response and survival. The authors hypothesised that increased expression and unmethylated promoter of the CRBP1 gene could be considered as markers for larynx cancer.

18 November 2011 in Infectious Agents and Cancer
Verified
Journal Article
Open access
PDF file
RPRaúl Peralta
Raúl Peralta
AVAlejandra Valdivia
Alejandra Valdivia
PEPerla Estañol
Perla Estañol
VVVanessa Villegas-Ruíz
Vanessa Villegas-Ruíz
AVAlejandra Valdivia-Flores
Alejandra Valdivia-Flores
MSMauricio Salcedo
Mauricio Salcedo
Background: The relationship between Human Papillomavirus (HPV) infection and conjunctiva cancer is controversial. HPV detection will provide more information about the role of this infectious agent in the biology of conjunctiva cancer. In the present study, DNA extracted and purified from 36 Conjunctival Squamous Cell Carcinomas (CSCC) was evaluated by PCR for HPV DNA sequences. The results were correlated with the clinical and histopathological variables. Results: The results showed that HPV DNA was present in 8 CSCC samples (22%); HPV16 was the sole type detected. Significant association was found between HPV detection and the limbus tumor subtype (p = 0.03). All the samples were non-metastatic squamous cell carcinoma. Conclusions: The HPV presence in CSCC from Mexican patients is not a common event.

15 August 2013
Verified
Journal Article
Closed access
MMMónica Mendoza-Rodriguez
Mónica Mendoza-Rodriguez
HAHugo Arreola
Hugo Arreola
AVAlejandra Valdivia
Alejandra Valdivia
RPRaúl Peralta
Raúl Peralta
HSHumberto Serna
Humberto Serna
MSMauricio Salcedo
Mauricio Salcedo